IMA Advisory Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

IMA Advisory Services’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$450	Hold	15	–	–	﹤0.01%	876
2025 Q4	$490	Buy	+15	New	+$484	﹤0.01%	864

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IMA Advisory Services's LKFT Position: Q1 2026 in Review

IMA Advisory Services held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q1 2026 at 15 shares worth $450. The position accounts for ﹤0.01% of the portfolio, ranked #876.

IMA Advisory Services first reported a position in LKFT in Q4 2025 and has held it in 2 quarters since. The position peaked at $490 in Q4 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

IMA Advisory Services held 15 shares of Lakefront Biotherapeutics American Depositary Shares worth $450 as of Q1 2026.
IMA Advisory Services left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q1 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of IMA Advisory Services's portfolio in Q1 2026, its #876 holding.
IMA Advisory Services first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2025 and has held it in 2 quarters since.
IMA Advisory Services's Lakefront Biotherapeutics American Depositary Shares position peaked at $490 in Q4 2025.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.